'Human Barbie' Marcela Iglesia To Use Son's Blood To Stay Young

Marcela Iglesia, a 47-year-old who describes herself as a 'self-proclaimed' human Barbie, has sparked controversy with her plans to undergo a blood transfusion from her son, Rodrigo.

Iglesia, known for her presence on the internet, believes this procedure will help her maintain a youthful appearance. She revealed that her son was more than willing to contribute to her anti-ageing regimen and was also considering doing the same for his grandmother. "Blood transfusion is the new era of maintaining young cells in your system especially when it comes from your own son or daughter," Iglesia explained, highlighting the perceived benefits of receiving blood from a younger family member.

The Los Angeles-based internet personality provided insight into the process, noting that blood transfusions can rejuvenate the body by introducing fresh red blood cells that enhance oxygen circulation.

Marcela Iglesia emphasized the role of plasma in carrying proteins and aiding with clotting, which can be beneficial for healing. According to her, this treatment promises to leave recipients feeling more robust and supported, akin to a traveler revitalized by water after a long journey. She stumbled upon this unconventional beauty treatment after experimenting with stem cell therapy, convinced of its potential to reverse signs of aging.

However, Iglesia's decision has drawn sharp criticism from social media users, with many questioning the ethics and rationale behind such a procedure. Comments ranged from outright disbelief to concern for Rodrigo, with one user suggesting, "Dear Rodrigo, when you realise that you need therapy to deal with your mother issues, please reach out." This backlash underscores the controversial nature of using blood transfusions for cosmetic purposes, a topic that has clearly divided public opinion.

Official Concerns Over Blood Transfusion Treatments

The US Food & Drug Administration (FDA) has issued warnings against the use of blood transfusions for conditions unrelated to medical necessity, encompassing a broad spectrum of issues from normal aging and memory loss to severe ailments such as dementia, Parkinson's disease, multiple sclerosis, Alzheimer's disease, heart disease, or post-traumatic stress disorder. The FDA's caution reflects the potential risks and unproven benefits of such treatments, highlighting the need for a cautious approach to these experimental practices.

In conclusion, Marcela Iglesia's plan to receive a blood transfusion from her son as an anti-aging treatment has ignited a debate about the ethics and safety of such procedures. While she remains convinced of the benefits, citing personal research and previous treatments, the backlash from the online community and warnings from the FDA suggest a more skeptical viewpoint. As the conversation around unconventional beauty treatments continues, it serves as a reminder of the lengths to which individuals will go in pursuit of youth and the importance of regulatory oversight in safeguarding public health.